98%
921
2 minutes
20
Objective: The purpose of this pilot trial was to evaluate the novel use of Brief Behavioral Treatment for Insomnia (BBTI) for people with residual insomnia disorder following eating disorder (ED) treatment.
Methods: Participants (N = 6) completed a multiple-baseline design study of BBTI. The primary outcome was insomnia severity, measured by the Insomnia Severity Index. Secondary outcomes included sleep efficiency and daytime fatigue. Exploratory outcomes were ED-related impairment and symptoms, anxiety symptoms, and depression symptoms.
Results: BBTI reduced insomnia symptom severity from baseline to end of treatment. BBTI also resulted in improvements in sleep efficiency and reductions in daytime fatigue. ED-related and other psychopathology outcomes largely did not change.
Discussion: BBTI showed preliminary evidence of efficacy, acceptability, and feasibility among people with residual insomnia following ED treatment. Future studies should use randomized controlled designs to better elicit the effects of BBTI on ED-related outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/eat.24540 | DOI Listing |
J Marital Fam Ther
October 2025
Department of Psychology, University of Toronto, Toronto, Ontario, Canada.
Chapman's Five Love Languages have been embraced by the public and incorporated into therapeutic practice, offering a simple framework for expressing and receiving love. However, it is unclear whether the proposed five love languages fully capture the multitude of ways that individuals express love. In three studies with individuals in long-term relationships residing in the United States (N = 696, 500, 499), we used a bottom-up approach to revise a previously developed measure of love languages using exploratory and confirmatory factor analyses.
View Article and Find Full Text PDFNan Fang Yi Ke Da Xue Xue Bao
August 2025
Department of Encephalopathy, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
Objectives: To exple the mechanism of Granules (QXZG) for enhancing synaptic plasticity in aging rats.
Methods: Forty SD rats were randomized into control group, aging model group, donepezil treatment group, and QXZG treatment group (=10). Except for the control rats, all the rats were subjected to daily intraperitoneal injection of D-galactose for 8 consecutive weeks to induce brain aging, and donepezil hydrochloride and QXZG suspension were administered by gavage during modeling.
Int J Eat Disord
September 2025
Department of Psychology, Wesleyan University, Middletown, Connecticut, USA.
Objectives: Generative Artificial Intelligence (AI) could transform how science is conducted, supporting researchers with writing, coding, peer review, and evidence synthesis. However, it is not yet known how eating disorder researchers utilize generative AI, and uncertainty remains regarding its safe, ethical, and transparent use. The Executive Committee of the International Journal of Eating Disorders disseminated a survey for eating disorder researchers investigating their practices and perspectives on generative AI, with the goal of informing guidelines on appropriate AI use for authors, reviewers, and editors.
View Article and Find Full Text PDFAlzheimers Dement
September 2025
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.
Introduction: Risperidone is approved for behaviors and psychological symptoms of dementia (BPSD), despite modest efficacy and known risks. Identifying responsive symptoms, treatment modifiers, and predictors is crucial for personalized treatment.
Method: A one-stage individual participant data meta-analysis of six randomized controlled trials (risperidone: n = 1009; placebo: N = 712) was conducted.
Encephale
September 2025
Université de Reims Champagne-Ardenne, C2S, Reims, France; Groupe Hospitalier Paul-Guiraud, GHT Psy Sud, Boulogne-Billancourt, France. Electronic address:
Objectives: This systematic review aims to evaluate the impact of cognitive-behavioral and metacognitive therapies on cognitive and clinical insight into early schizophrenia disease.
Methods: A comprehensive literature review was conducted across several databases, including Pubmed, PsycINFO, and Cochrane Library, focusing on studies published between 2006 and May 2024. The studies selected for this review were either randomized controlled trials (RCTs), cross-sectional studies, or exploratory studies.